Literature DB >> 15804699

Antinuclear antibodies.

Yoshinao Muro1.   

Abstract

The presence of abnormal levels of autoantibodies to intracellular antigens is a hallmark of systemic connective tissue disease. The indirect immunofluorescence assay is the most commonly used routine test for the detection of antinuclear antibodies. In this text, several representative patterns of fluorescence are reviewed and some pitfalls for application of the results to the clinical field are mentioned.

Mesh：

Substances：

Year:  2005        PMID： 15804699     DOI： 10.1080/08916930400024612

Source DB:  PubMed          Journal:  Autoimmunity        ISSN： 0891-6934            Impact factor:   2.815


  14 in total

Review 1.  Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.

Authors:  Sean R Christensen; Mark J Shlomchik
Journal:  Semin Immunol       Date:  2007-02-02       Impact factor: 11.130

2.  Determination of cut-off titers and agreement between immunofluorescence and immunoblotting methods for detecting antinuclear antibodies in children.

Authors:  G Aksu; N Gulez; E Azarsiz; N Karaca; N Kutukçuler
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Comparative study of immunofluorescent antinuclear antibody test and line immunoassay detecting 15 specific autoantibodies in patients with systemic rheumatic disease.

Authors:  Sun Ah Lee; Jimin Kahng; Yonggoo Kim; Yeon-Joon Park; Kyungja Han; Seung-Ki Kwok; Sung-Hwan Park; Eun-Jee Oh
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

4.  Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.

Authors:  Yanwei Wu; Shijun He; Bingxin Bai; Luyao Zhang; Lu Xue; Zemin Lin; Xiaoqian Yang; Fenghua Zhu; Peilan He; Wei Tang; Jianping Zuo
Journal:  Cell Mol Immunol       Date:  2015-03-16       Impact factor: 11.530

5.  The relationship between pemphigus and systemic lupus erythematosus: a cross-sectional study, systematic review, and meta-analysis.

Authors:  Khalaf Kridin; Rimma Laufer-Britva; Mouhammad Kridin; Doron Comaneshter; Erez Batat; Arnon D Cohen
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

6.  Scavenging nucleic acid debris to combat autoimmunity and infectious disease.

Authors:  Eda K Holl; Kara L Shumansky; Luke B Borst; Angela D Burnette; Christopher J Sample; Elizabeth A Ramsburg; Bruce A Sullenger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-15       Impact factor: 11.205

Review 7.  Toll-like receptors: potential targets for lupus treatment.

Authors:  Yan-wei Wu; Wei Tang; Jian-ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

8.  Markers of autoimmune liver diseases in postmenopausal women with osteoporosis.

Authors:  Umit Secil Demirdal; Ihsan Hakkı Ciftci; Vural Kavuncu
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

9.  Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.

Authors:  Yoshinao Muro; Yuji Hosono; Kazumitsu Sugiura; Yasushi Ogawa; Tsuneyo Mimori; Masashi Akiyama
Journal:  Arthritis Res Ther       Date:  2015-03-11       Impact factor: 5.156

10.  BAFF and MyD88 signals promote a lupuslike disease independent of T cells.

Authors:  Joanna R Groom; Carrie A Fletcher; Stacey N Walters; Shane T Grey; Sally V Watt; Mathew J Sweet; Mark J Smyth; Charles R Mackay; Fabienne Mackay
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.